The most common complication from L-dopa therapy is dyskinesias, for which deep-brain stimulation has proven helpful [Aasly et al 2005, Gosal et al 2005, Hernandez et al 2005, Goldwurm et al 2006, Ishihara et al 2006, Tomiyama et al 2006].

Other preventions for L-dopa induced dyskinesias include constant drug delivery/stimulation (CDD/CDS) [Jenner 2008], reduction of levodopa doses [Goetz et al 1982] and the use of dopamine receptor agonists [Holloway & Frank 2004, Holloway et al 2004].
